NeuroMetrix Announces 2020 Annual Meeting of Shareholders Will Be Held in Virtual Meeting Format Only

WOBURN, Mass., April 10, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today announced that, due to the public health impact of the COVID-19 pandemic and in accordance with orders issued by the Governor of the Commonwealth of Massachusetts, the Company’s 2020 Annual Meeting of Shareholders (the “Annual Meeting”) will be held in a virtual meeting format only. The previously announced date and time of the Annual Meeting (April 28, 2020 at 9:00 a.m., Eastern Time) have not changed. The link to the virtual meeting is
As described in the proxy materials for the Annual Meeting previously distributed, you are entitled to participate in the Annual Meeting if you were a shareholder as of the close of business on March 2, 2020, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee.  Shareholders who wish to attend the Annual Meeting must register by 11:59 p.m., Eastern Time, on April 26, 2020, by clicking on “Virtual Meeting Registration” at Shareholders will be provided an opportunity to ask questions of the Board of Directors and management during the meeting using the directions on the meeting website that day. Please refer to the 2020 Annual Meeting FAQ’s included in the “Virtual Meeting Registration” section of the website for further registration instructions and technical support.The Company encourages eligible shareholders to vote on the proposals prior to the Annual Meeting using the instructions included in the proxy instructions previously distributed. The proxy card included with the proxy materials previously distributed will not be updated to reflect the change in location and may continue to be used to vote shares in connection with the Annual Meeting. Shareholders will also have the opportunity to vote their shares during the Annual Meeting by following the instructions available on the meeting website during the meeting.About NeuroMetrixNeuroMetrix is a leading developer and manufacturer of diagnostic and therapeutic neurostimulation-based medical devices that are used throughout the world.  The Company has three FDA cleared commercial products.  DPNCheck® is a point-of-care test that is used to evaluate peripheral neuropathies.  ADVANCE is a point-of-care device that provides nerve conduction studies as an aid in diagnosing and evaluating patients suspected of having focal or systemic neuropathies.  Quell® 2.0 is a wearable, mobile app enabled, neurostimulation device indicated for symptomatic relief and management of chronic pain and is available OTC.  The Company maintains an active, industry-leading R&D program.  For more information, visit, Inc.Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Source: NeuroMetrix, Inc. 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.